Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Benary

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2023
Tumour mutational burden and survival with molecularly matched therapyTill de Bortoli, Manuela Benary, Peter Horak, et al.
Journal of the American Medical Informatics Association : JAMIA|April 20, 2023
Creation of a structured molecular genomics report for Germany as a local adaption of HL7's Genomic Reporting Implementation GuideCaroline Stellmach, Julian Sass, Bernd Auber, et al.
The Oncologist|April 22, 2026
Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLCStanislav Rosnev, Katharina Klein, Lukas Heukamp, et al.
BMC Medicine|October 24, 2022
Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boardsDamian T Rieke, Till de Bortoli, Peter Horak, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2020
Support of a molecular tumour board by an evidence-based decision management system for precision oncologyMario Lamping, Manuela Benary, Serge Leyvraz, et al.
The Oncologist|June 17, 2024
A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric massStefan Habringer, Jana Ihlow, Karsten Kleo, et al.
Nature Cancer|June 28, 2024
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunitiesEvelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
Benchmarking whole exome sequencing in the German network for personalized medicineMichael Menzel, Mihaela Martis-Thiele, Hannah Goldschmid, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2023
Tumour mutational burden and survival with molecularly matched therapyTill de Bortoli, Manuela Benary, Peter Horak, et al.
Journal of the American Medical Informatics Association : JAMIA|April 20, 2023
Creation of a structured molecular genomics report for Germany as a local adaption of HL7's Genomic Reporting Implementation GuideCaroline Stellmach, Julian Sass, Bernd Auber, et al.
The Oncologist|April 22, 2026
Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLCStanislav Rosnev, Katharina Klein, Lukas Heukamp, et al.
BMC Medicine|October 24, 2022
Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boardsDamian T Rieke, Till de Bortoli, Peter Horak, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2020
Support of a molecular tumour board by an evidence-based decision management system for precision oncologyMario Lamping, Manuela Benary, Serge Leyvraz, et al.
The Oncologist|June 17, 2024
A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric massStefan Habringer, Jana Ihlow, Karsten Kleo, et al.
Nature Cancer|June 28, 2024
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunitiesEvelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
Benchmarking whole exome sequencing in the German network for personalized medicineMichael Menzel, Mihaela Martis-Thiele, Hannah Goldschmid, et al.
Pageof 2